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Endogenous TRPV1 stimulation leads to the activation of the inositol
phospholipid pathway necessary for sustained Ca2+ oscillations
László Pecze ⁎, Walter Blum, Thomas Henzi, Beat Schwaller
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Sensory neuron subpopulations as well as breast and prostate cancer cells express functional transient receptor 
potential vanilloid type 1 (TRPV1) ion channels; however little is known how TRPV1 activation leads to biological 
responses. Agonist-induced activation of TRPV1 resulted in speciﬁc spatiotemporal patterns of cytoplasmic Ca2+
signals in breast and prostate cancer-derived cells. Capsaicin (CAPS; 50 μM) evoked intracellular Ca2+ oscillations 
and/or intercellular Ca2+ waves in all cell lines. As evidenced in prostate cancer Du 145 cells, oscillations were 
largely dependent on the expression of functional TRPV1 channels in the plasma membrane, phospholipase C 
activation and on the presence of extracellular Ca2+ ions. Concomitant oscillations of the mitochondrial matrix 
Ca2+ concentration resulted in mitochondria energization evidenced by increased ATP production. CAPS-
induced Ca2+ oscillations also occurred in a subset of sensory neurons, yet already at lower CAPS concentrations 
(1 μM). Stimulation of ectopically expressed TRPV1 channels in CAPS-insensitive NIH-3T3 cells didn't provoke 
CAPS-triggered Ca2+ oscillations; rather it resulted in low-magnitude, long-lasting elevations of the cytosolic 
Ca2+ concentration. This indicates that sole TRPV1 activation is not sufﬁcient to generate Ca2+ oscillations. In-
stead the initial TRPV1-mediated signal leads to the activation of the inositol phospholipid pathway. This in 
turn sufﬁces to generate a biologically relevant frequency-modulated Ca2+ signal.
1. Introduction
Calcium ions (Ca2+), universal signaling molecules, are widely rec-
ognized to play a fundamental role in the regulation of various biologi-
cal processes. Many cytosolic and mitochondrial activities are driven in
a Ca2+-dependent manner. Therefore, each cell possesses sophisticated
mechanisms for the precise regulation of cytoplasmic (ccyt), endoplas-
mic reticulum luminal (cER) andmitochondrial matrix (cmito) Ca2+ con-
centrations. Since Ca2+ regulates the cell cycle at several stages, Ca2+
signaling is importantly involved in cell-fate determination (quiescent
state, proliferation or cell death). Mitogenic compounds such as
platelet-derived growth factor, vasopressin, prostaglandin, bombesin
or EGF evoke repetitive Ca2+ transients and also induce inositol tris-
phosphate (InsP3) production [1,2]. In Swiss 3T3 cells, increases in ccyt
evoked by mitogenic compounds are essential, but not sufﬁcient to in-
duce DNA synthesis and proliferation [3]. Moreover the frequency of
base-line spiking Ca2+oscillations in cultured human embryonic kidney
(HEK) cells is directly related to cell proliferation [4]. In postmitotic neu-
rons, Ca2+ oscillations regulate a variety of neuronal processes
including excitability, associativity, neurotransmitter release, synaptic
plasticity and gene transcription [5].
The signaling process leading to Ca2+ oscillations is composed of
the following steps: I) A ligand binds to its receptor coupled to
heterotrimeric G proteins, II) the Gαq subunit of a heterotrimeric G pro-
tein dissociates from the G protein-receptor complex and activates
phospholipase C, III) phospholipase C hydrolyzes phosphatidylinositol
4,5-bisphosphate (PIP2) to inositol 1,4,5-trisphosphate (InsP3), which
then releases Ca2+ from intracellular stores via binding to the inositol
trisphosphate receptor (InsP3R) [6] and diacylglycerol (DAG), which ac-
tivates protein kinase C (PKC) and IV) activation of InsP3R by InsP3 leads
to the quantal release of Ca2+ ions from the endoplasmic reticulum [7].
The shape of the Ca2+ signal is correlated with the InsP3 concentration,
i.e. the stimulation intensity: weak activation results in single Ca2+
spikes, increasing the stimulation leads to slowbase-line spiking oscilla-
tions, followed by fast base-line spiking oscillations, sinusoidal Ca2+
oscillations and ﬁnally non-oscillating signal-plateau Ca2+ responses
[8]. Of note, Ca2+ oscillations occur within a certain range of agonist
stimulation. Ryanodine receptors have structural and functional simi-
larity to InsP3R, but show no sensitivity to InsP3 [9]. One of the functions
of ryanodine receptors is to amplify the InsP3-mediated release of Ca2+
[10]. The unique bell-shaped dependence of InsP3R and ryanodine re-
ceptors on ccyt allow for the repetitive release of Ca2+ ions from the en-
doplasmic reticulum [11]. This is what is observable as Ca2+ oscillations.
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The transient receptor potential cation channel subfamily Vmember
1 (TRPV1) triggers intracellular signalingmechanisms by an increase of
ccyt, when it is activated by multiple pain-inducing stimuli including
heat, acids and pungent compounds [12]. TRPV1 is activated by selective
potent natural agonists such as capsaicin (CAPS) and resiniferatoxin
(RTX), pungent compounds found in chili pepper and in a tropical
plant called Euphorbia resinifera, respectively [13]. Upregulation of
TRPV1 channels in neoplastic breast and prostate tissue compared to
normal tissue has been reported before [14,15], but little is known
about the channel's physiological function and the likely pathological
consequences in these neoplasms. Virtually all pharmacological and
molecular methods used to examine the function of these channels re-
sulted in a decrease of cell viability. These methods included molecular
up- or downregulation of the channels and activation or inhibition of
channels with natural exogenous agonists or synthetic antagonists
[16,17]. The activation of these channels leads to an increase in ccyt in
breast and prostate cell lines, but the previously published studies pre-
sented only the average of evoked Ca2+ cytoplasmic signals within the
entire cell populations [17–19]. This method blurs the spatiotemporal
character of individual intracellular Ca2+ signals, which is essential to
understand how TRPV1-mediated stimuli inﬂuence the cell behavior
at the single cell level.
In this study, spatiotemporal recordings of ccyt and cmito were
collected and analyzed; moreover selected mitochondrial functions
(membrane potential, ATP production) were analyzed as well. The re-
sults revealed the connection between TRPV1 channels and the inositol
phospholipid pathway and moreover how TRPV1-mediated Ca2+ sig-
nals are processed to biologically relevant frequency-modulated Ca2+
oscillations. It is known that TRPV1 channels are modulated by phos-
pholipids such as PIP2 [20,21], but our results revealed that the
activation of endogenous TRPV1 leads to the production of inositol tris-
phosphate, thereby reducing the levels of PIP2 in the plasmamembrane
creating a negative feedback loop.
2. Materials and Methods
2.1. Reagents
Capsaicin (CAPS), a TRPV1 agonist and capsazepine (CapZ), a well-
characterized antagonist of TRPV1 were dissolved in DMSO at a
concentration of 100 mM (all from Sigma-Aldrich, St. Louis, MO).
Resiniferatoxin (RTX) from the LC Laboratories (Woburn, MA) was dis-
solved in ethanol at a concentration of 2 mM. 13(S)-Hydroxyoctadeca-
9Z,11E–dienoic acid (13(S)-HODE), an endogenous agonist of TRPV1
was obtained from Sigma-Aldrich. Suramin from Adipogen (Liestal,
Switzerland) was dissolved in double distilled water. Phospholipase C
inhibitor U-73122 were from Tocris (Ellisville, MO). The compounds
were further diluted with buffer solution used for Ca2+-imaging exper-
iments that contained (in mM): NaCl 138, Na2PO4 8, CaCl2 2, MgCl2 0.5,
KCl 2.7, KH2PO4 1.6; pH 7.4. The ﬁnal concentration of the solvents were
b0.1% in all experimental solutions. At these concentrations the solvents
did not affect/modify the evoked Ca2+ responses in control experiments
(data not shown). Ethylene glycol tetra acetic acid (EGTA) was dis-
solved with NaOH in double distilled water at basic pH (pH N 8.0) and
then the pH was adjusted to 7.4 with HCl. The nuclear stain Hoechst
33,342, the mitochondrial marker MitoTracker Red CMXRos and the
plasma membrane marker CellMask™-Orange were purchased from
Thermo Fisher Scientiﬁc Inc. (Waltham, MA).
2.2. Plasmids and cell lines
The cDNA of the human TRPV1 channel (hTRPV1) was ampliﬁed
from RNA isolated from human trigeminal ganglion tissue as previously
described [22]. The pGFP-TRPV1 plasmid resulting in a GFP-TRPV1
fusion protein, as well as the plasmid pTRPV1 encoding full-length
TRPV1 were used in this study. The plasmid encoding InsP3 5-
phosphatase (pIRES-InsP3–5P-GFP) was a kind gift from Christophe
Erneux, IRIBHM, Bruxelles [23]. The BFP-KDEL plasmid for ER visualiza-
tion was a gift from Gia Voeltz; Addgene plasmid #49,150. The
mCherry-hCdt1 plasmid was a kind gift of Prof. H. Miyoshi (Riken,
Japan). This plasmid was used to label nuclei in red color. The control
plasmid pEGFP-C1 coding for EGFP was from Clontech (Palo Alto, CA).
In order to generate lentivirus encoding the red Ca2+ indicator CAR-
GECO1 (the CMV-CAR-GECO1plasmidwas a gift fromRobert Campbell;
Addgene plasmid #45,493), a fragment encoding CAR-GECO1 was
cloned into lentiviral expression vector pLVTHM (pLVTHM was a gift
from Didier Trono; Addgene plasmid # 12,247)). The GFP cassette in
pLVTHM was replaced with cDNAs coding for the respective Ca2+
indicator proteins. Brieﬂy, the required cDNA fragment coding for full-
length CAR-GECO1 was synthesized by PCR using the primers
FW_PmeI_Car-Geco1 (5′- CTT TGT TTA AAC ATG GTC GAC TCA TCA
CGT-3′) and RV_NdeI_Car-Geco1 (5′-ATT CCA TAT GCT ACT TCG CTG
TCA TCA T-3′). The amplicon was digested with PmeI and NdeI and
inserted into the unique sites of the pLVTHM vector to produce the
ﬁnal pLV-CAR-GECO1 plasmid. The lentivirus was produced by the cal-
cium phosphate transfection method using HEK 293 cells and three
plasmids: one of the expression plasmids (e.g. pLV-CAR-GECO1 or
pLV-mito-CAR-GECO1), the envelope plasmid (pMD2G–VSVG Addgene
plasmid #12,259) and the packaging plasmid (psPAX2, Addgene plas-
mid #12,260). Viral containing supernatants were collected after 48 h
and 72 h, ﬁltered, aliquoted and frozen at−80 °C, as described before
[24]. Human prostate (PC-3, LNCaP, Du 145) and breast (MCF7, BT-
474, MDA-MB-231) cancer cell lines and HEK 293 cells of human em-
bryonic kidney origin were purchased from ATCC (Manassas, VA,
USA). Non-transfected NIH-3T3 and rat TRPV1-expressingNIH-3T3mu-
rine ﬁbroblast cells (NIH-3T3rTRPV1) were a kind gift from Dr. Zoltan
Olah, University of Miskolc, Hungary. In NIH-3T3rTRPV1 cells, the metal-
lothionein promoter is used to drive the expression of full-length rat
TRPV1 with a short 12 amino acid ε-tag [25]. Cells were cultivated in
DMEM containing 10% fetal calf serum and antibiotics (penicillin and
streptomycin) at 37 °C/5% CO2. DRG primary cultures were prepared
from E15 rat embryos as previously described [22]. DRG cell cultures
were maintained in DMEM containing 5% horse serum and 100 ng/ml
nerve growth factor (Sigma-Aldrich) to promote neuronal survival
and differentiation. After 2 days in vitro primary DRG cultures were
used for the experiments. Du 145 cells stably expressing the Ca2+ indi-
cator protein CAR-GECO1 was generated with lentiviral infection. In
some experiments, Du 145, MCF7, HEK 293 and NIH-3T3 cells were
transiently transfected using the TransIT-2020 transfection reagent
according to manufacturer's instructions (Myrus, Madison, WI).
2.3. Immunoﬂuorescence staining
Cells were prepared for immunoﬂuorescence analysis as described
previously [26]. As a positive control, MCF7 cells were transiently
transfected with plasmids encoding human TRPV1 cDNA. The following
antibodieswere used for staining: anti-TRPV1 (1:500; rabbit polyclonal,
Alomone Labs #ACC-030), Cell nuclei were stained with 5 μg/ml DAPI
(Invitrogen) in Tris-buffered saline for 10 min, and mounted with
Hydromount solution (National Diagnostics, Atlanta, GA). Images were
acquired with a confocal microscope DMI6000 integrated to a Leica
TCS-SP5 workstation (Leica, Wetzlar, Germany).
2.4. Ca2+ imaging
Cells grown on collagen-coated glass bottom 35 mm dishes (MatTek
Corp., Ashland, MA) were loaded with the cell permeable acetoxymethyl
(AM)-ester form of the indicator dyes. The following dyes were used: for
the cytoplasmic free Ca2+ concentration (ccyt): Fluo-4-AM (1 μM; Life
Technologies, Grand Island, NY) and for the mitochondrial free Ca2+
concentration (cmito): Rhod-2-AM (1 μM; Life Technologies) diluted in
cell culture media for 20 min at room temperature. After loading cells
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encoded Ca2+ indicator CAR-GECO1. At the confocal microscope,
ﬂuorescence emission was recorded at 419–474 nm (Hoechst 33342,
BFP-KDEL), 510–554 nm (Fluo-4, GFP) and 584 to 683 nm (Rhod-2,
CAR-GECO1, MitoTracker Red CMXRos, mCherry-hCdt1) in a sequential
mode. Recordings were performed at 37 °C using Tempcontrol 37–2 dig-
ital, and a Heating Stage, all from PeCon GmbH (Erbach, Germany). The
drugs were added to the abovementioned solutions by pipette and
remained in the solution until the end of the experiments. Fluorescence
images for either ccyt or cmito measurements were collected simulta-
neously. Circular-shaped regions of interest (ROI) were placed inside
the cytoplasmic area of cells. The ﬂuorescence values were calculated
after background subtraction (ﬂuorescence intensity of regions without
cells). Bleaching correction was carried out, when the baseline was not
stable. The relative ﬂuorescent unit (F(t)/F(0)) values were calculated
for each cell; ﬂuorescence intensities at each time point were divided
by the averaged baseline ﬂuorescence value measured during the non-
treatment period. In order to gain insight into evoked Ca2+ responses of
the entire cell population, the traces of N20 randomly selected cells
were averaged and standard deviations were calculated (grey traces on
ﬁgures). Each experimental procedure was repeated at least two times
with similar results, but only one series of experiments is reported for
each case. The percentage of the responding cells was calculated in each
case. The lowest and highest values are presented from the results of
three independent experiments. Computerized peak recognition for
frequency was realized via the Microsoft Excel 2010 environment as
described before [27]; normalized recordings from 20 oscillating cells
were evaluated. The oscillation frequency was determined for time
window 1–5 min after CAPS administration. The LAS-AF (Leica, Wetzlar,
Germany) and Prism3 (GraphPad Software, Inc., San Diego, CA) software
were used for data analysis.
2.5. Measurement of mitochondrial function
Mitochondrial membrane potential (ΔΨ) measurements were per-
formed using the Rhodamine 123 dye. Brieﬂy, cells were seeded on
glass-bottom Petri dishes and incubated with 10 μM Rhodamine 123
for 20 min at room temperature. Cells were washed three times with
DPBS buffer. During the recording using the confocal microscope, the
488 nm excitation wavelength was used to illuminate Rhodamine 123.
The relative mitochondrial membrane potential (ΔΨ) for a single cell
was determined according to the following calculation: the ﬂuorescent
intensity of Rhodamine 123 in the cytoplasmic region was divided by
that of the nuclear region. Then, the single-cell values were normalized
to the average values recorded in the non-treated period (taken as 100%
value) and the average values recorded after CCCP treatment (taken as
0% value). The mean and standard deviation were calculated from at
least 20 individual cell recordings. Relative ATP levels were determined
using the ATP Bioluminescence Assay Kit CLS II (Roche, Basel,
Switzerland). Du 145 cells were seeded into a 96-well plate (10,000
cells/well) and grown overnight at 37 °C. The medium was removed
and replaced by 100 μl fresh medium containing capsaicin, capsaicin/
CCCP or DMSO (equal volume as used for the treatments). After an incu-
bation time of 0, 2 and 5 min, 100 μl 2× passive lysis buffer (Promega,
Dübendorf, Switzerland) were added. Samples (50 μl) were pipetted
into a black 96-well plate and 50 μl luciferase reagents were added
GFP and InsP3–5 phosphatase or with plasmid encoding only GFP at
50% conﬂuency in 24-well plates. Cells were monitored using the Live
Cell Imaging System (Incucyte, EssenBioScience, Michigan, USA) by ac-
quiring images every 1 h. In another experiment, cellswere stainedwith
Annexin V-Cy3 (Enzo Life Sciences, Lausen, Switzerland) to identify ap-
optotic cells following the manufacturer's instruction. Bright ﬁeld and
ﬂuorescent images were collected using an inverted ﬂuorescence mi-
croscope DMI6000B (Leica).
3. Results
3.1. Intracellular localization of TRPV1 channels in cancer cell lines
As shown previously [22] all cancer cell lines used in this study ex-
press TRPV1 channels evidenced at both, mRNA and protein levels.
However, protein expression levels of TRPV1 are much lower in cancer
cells than in sensory neurons [22]. Immunoﬂuorescence analysis of
TRPV1 expression in prostate and breast cancer cell lines revealed rath-
er homogenous, not mosaic–like expression of TRPV1 in all 6 cell lines.
The immunoﬂuorescence signal was mostly localized to intracellular
membrane compartments, most prominently in the endoplasmic retic-
ulum (Fig. 1A). Addition of the blocking peptides for the TRPV1 antibod-
ies to the staining solutions resulted in a complete loss of the green
immunoﬂuorescence evidenced in MCF7 cells. MCF7 cells overexpress-
ing either human or rat TRPV1 channels served as positive controls;
strong greenmosaic immunoﬂuorescencewas observed in cells overex-
pressing TRPV1 distinguishing the transfected (strong green ﬂuores-
cence) from the untransfected ones (Fig. 1A, lower row, right image).
The intracellular localization of TRPV1 in living MCF7 cells was visual-
ized by transfection-mediated expression of GFP-labeled TRPV1 recep-
tor. TRPV1 did neither co-localize with mitochondria that were loaded
with MitoTracker Red CMXRos nor with cell nuclei labeled with blue
Hoechst 33,342 (Fig. 1B, ﬁrst row). TRPV1 was also clearly expressed
on the plasmamembrane evidenced by the colocalization of the plasma
membrane marker CellMask™-Orange and GFP-TRPV1 (Fig. 1B, second
row). Strong colocalizationwas evident in cellsmaking cell/cell contacts
(yellow labeling; arrows). Results from a previous study, i.e. the ability
of TRPV1-expressing cells to accumulate 45Ca2+ ions from the extracel-
lular medium (45Ca2+ uptake assay) [22] are in support of the
colocalization study that indeed functional TRPV1 channels are present
within the plasma membrane. TRPV1 showed co-localization with ER
compartments, the latter visualized with blue ﬂuorescent protein hav-
ing an ER-retention signal, KDEL (Fig. 1B, third row). Nuclei of these
cells were visualized with hCdt1-mCherry, a nuclear-localized protein
fused to the red ﬂuorescent protein. In some cells (approximately 10%
of total cells), possibly representing early apoptotic cells, TRPV1 showed
an altered intracellular localization, characterized by a rather homoge-
neous cytoplasmic, as well as nuclear distribution. These cells had
huge vacuolar-like intracellular vesicles and a disorganized ER structure
(Fig. 1B, last row).
3.2. Analyses of the CAPS-induced changes in ccyt in carcinoma cell lines
Changes in ccyt were monitored with Fluo-4. Representative ccyt sig-
nals for breast cancer cell lines exposed to CAPS (50 μM) are depicted in
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Fig. 1. Expression of TRPV1 channel protein in prostate and breast cancer cell lines. A. Immunohistochemical staining for TRPV1 of the 6 cancer cell lines (upper row, prostate cancer
cells; lower row, breast cancer cells) showed mostly intracellular localization of TRPV1 channels, likely in ER compartments. Nuclei were counterstained with DAPI. To demonstrate
speciﬁcity of IHC the TRPV1 antibody was blocked by respective speciﬁc peptides in a MCF7 sample (upper row, right). MCF7 cells ectopically expressing human TRPV1 channel were
used as positive control (lower row, most right image: bar represents 25 μm). B. Fluorescence images show the intracellular localization of GFP-labeled TRPV1 channels in MCF7 cells.
TRPV1 doesn't not co-localize with mitochondria: TRPV1 (green), nucleus (blue), mitochondria (red) (ﬁrst row). TRPV1 present on plasma membranes: TRPV1 (green), nucleus (blue),
cell membrane (red) (second row). Strong colocalization at cell/cell contact sites (yellow; arrows). TRPV1 co-localizes with ER compartments in most cells: TRPV1 (green), cell nucleus
(red) and ER (blue) (third row). In few cases, TRPV1 shows diffuse cytoplasmic and nuclear staining: TRPV1 (green), cell nucleus (red) and ER (blue) (last row). Bar represent 25 μm.
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derived cell lines responded to CAPS administration with rapid
increases in ccyt often followed by intracellular Ca2+ oscillations
(Fig. 2D-F). In PC-3 (prostate) andMCF7 (breast) cancer cells, the stim-
ulationwith 1 μMRTXor 50 μMCAPS, respectively, additionally resulted
in intercellular Ca2+ waves (Fig. 2G). Ca2+ waves spreading through
cultured cells were either seen immediately after CAPS administration
or occasionally fewminutes later. In the case ofMCF7 cells, the area cov-
ered by the waves was sometimes restricted to only few adjacent cells,
but in sporadic occasions waves spread almost over the entire cell pop-
ulation in the observed area (772 × 772 μm). The Ca2+ wave velocity
was rather similar in both cell lines, 13.4 ± 3.2 μm/s in PC-3 cells and
11.0 ± 3.3 μm/s in MCF7 cells (Fig. 2G). Since LNCaP and BT-474 cells
grew in aggregates (i.e. on top of each other), Ca2+ waves could not
be examined in our experimental setting. The percentage of the
responding cells varied quite strongly between cell lines and also be-
tween experiments using the same cell lines: PC-3 (56–75%), LNCaP
(1–3%), Du 145 (65–72%) and breast MCF7 (5–71%), BT-474 (11–23%)
and MDA-MB-231 (21–49%). A more detailed statistical analysis is pre-
sented in the Supplementary Materials.
3.3. Mechanistic characterization of CAPS-evoked Ca2+ oscillations in Du
145 cells
in the generation of these oscillations were investigated in more detail.
Ca2+ transients in Du 145 were also elicited by 5 μM 13-S-
hydroxyoctadecadienoic acid (13-HODE; Supplementary Fig. S1), an en-
dogenous but weak agonist of TRPV1 resulting in 25–34% responding
cells (Fig. 3A). Moreover the ultrapotent and speciﬁc TRPV1 agonist
RTX (1 μM) also evoked Ca2+ signals in Du 145 cells (31–44%
responding cells; Fig. 3B). The selective and full antagonist of TRPV1
channels, CapZ (100 μM), nearly completely inhibits TRPV1-mediated
Ca2+ signals evoked by 5 μMCAPS in a heterologous expression system
[29]. Similarly, CAPS (5 μM) evoked Ca2+ signals in Du 145 cells; how-
ever the average signal was smaller than that evoked by 50 μM CAPS
(27–33% responding cells) and the oscillations immediately halted or
the frequency was highly reduced after CapZ (10 μM) administration
(Fig. 3C).When CapZ (100 μM)was administered before agonist stimu-
lation, CAPS-evoked responses were strongly reduced (Fig. 3D; only ap-
proximately 2–5% responding cells). CapZ also blocked around 45–60%
of spontaneous Ca2+ oscillations observable in 3–5% of Du 145 cells
(Supplementary Fig. S2). Ca2+ oscillations were dependent on phos-
pholipase C activation, since the addition the phospholipase C inhibitor
U-73122 blocked the CAPS-evoked oscillations in Du 145 cells (Fig. 3E).
When cells were pre-treated with 50 μM U-73122, CAPS treatment
didn't induce oscillations, only single Ca2+ transients were observed
in 14–22% of cells (Fig 3F) Activation of phospholipase C results in
Fig. 2. CAPS-evoked changes in the cytoplasmic free Ca2+ concentration (ccyt). A)-F) Single-cell (colored traces) and average ﬂuorescence recordings of the entire cell population (grey
traces) from time-lapse videos show changes in ccyt after CAPS administration. Bars represent standard deviations (s.d.). Each ﬁgure represents the results of one representative
experiment out of three with similar results. Experiments were repeated at least two times with similar results. BT-474 (A), MCF7 (B) and MDA-MB-231 (C) cells treated with CAPS
(50 μM) mostly showed immediate onset Ca2+ transients; with very brief delays similar increases were observed in neighboring cells often resulting in an intercellular Ca2+ wave (G).
Only very few LNCaP cells (1–3%) responded to CAPS (D). CAPS-evoked Ca2+ waves and Ca2+ oscillations in Du 145 (E) and PC-3 (F) prostate cancer cells. G) Time-lapse image series
of intercellular Ca2+ waves. The acquisition rate was set to 3 s. Blue and red colors depict lower and higher ﬂuorescence intensities, respectively. A Ca2+ wave in PC-3 cells was evoked
by administration of 1 μM RTX (upper row). A larger Ca2+ wave in MCF7 cells was evoked by 50 μM CAPS (lower row). Bar represents 150 μm.
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consider that both activation and inhibition of phospholipase C has an
effect on the phospholipid composition of the plasma membrane that
subsequently inﬂuences the sensitivity of TRPV1 channels [20,21]. The
importance of InsP3 in the generation of Ca2+ oscillations was further
veriﬁed by overexpression of the InsP3-metabolizing enzyme InsP3–5
phosphatase.When the enzymewas expressed fromaGFP polycistronic
construct, the GFP expression enabling the identiﬁcation of transfected
InsP3–5 phosphatase-producing cells, CAPS was still able to generate
small Ca2+ signals in 12–14% of GFP-positive cells (Fig. 3G). However,
Ca2+ oscillations completely disappeared. The non-transfected GFP-
negative neighbors showed regular oscillations (62–75% responding
cells) (Fig. 3G, yellow trace). In a control experiment, cells only express-
ing GFP showed oscillations indicating the GFP by itself had no effect on
the appearance of Ca2+ oscillations (Fig. 3H). Ryanodine (50 μM) caused
a brief block of the CAPS-evoked Ca2+ oscillations indicative of the im-
portance of ryanodine-sensitive stores for the maintenance of
oscillations in these cells (Fig. 3I). Importantly, the removal of extracel-
lular Ca2+ strongly diminished and in most cases abolished the CAPS-
evoked TRPV1-mediated effects;while the CAPS-induced immediate in-
crease in ccyt was essentially absent, spontaneous oscillations in few
cells (1–2%) were insensitive to extracellular Ca2+ elimination by high
external EGTA (10 mM) (Fig. 3J). Extracellular ATP (5 μM) also evoked
Ca2+ oscillations in 83–91% of Du 145 cells (Supplementary Fig. S3),
which were partially inhibited by 50 μM suramin, a blocker of ATP-
sensing purinergic receptors (Supplementary Fig. S4). Extracellular re-
lease of ATP had been found to play an important role in generation of
Fig. 3. The effect of simultaneous administration of TRP agonists. A)-L) Single-cell (colored traces) and average ﬂuorescence (grey traces) recordings from time-lapse videos show
changes in ccyt. Bars represent standard deviations (s.d.). Each ﬁgure represents the results of one representative experiment out of three with similar results. A) 13-HODE (5 μM), an
endogenous TRPV1 agonist, evoked weak Ca2+ responses. B) Ca2+ responses were evoked by administration of 1 μM RTX, a speciﬁc potent TRPV1 agonist. C) CapZ, a TRPV1 blocker,
administered after CAPS stopped or strongly decreased the frequency of CAPS-evoked Ca2+ oscillations in Du 145 cells. D) CapZ administered before CAPS strongly reduced the CAPS-
evoked response E) U-73,122, a phospholipase C inhibitor, blocked the CAPS-evoked Ca2+ oscillations. F) Cells pre-treated with 50 μM U-73122f didn't showed oscillations. G)
Overexpression of InsP3–5-phosphatase hydrolyzing InsP3 concomitant with GFP protein expression inhibited CAPS-induced oscillations (single cell recordings in red, blue and green
color). Grey and yellow traces represents average ﬂuorescence recordings from cells with or without InsP3-hydrolysing enzyme from the same culture dish, respectively H) GFP
expression alone had no effect on oscillations (single cell recordings in red, blue and green color). Grey and yellow traces represents average ﬂuorescence recordings from cells with or
without GFP from the same culture dish, respectively I) Ryanodine (50 μM) transiently inhibited the Ca2+ oscillations. J) In the absence of external Ca2+ ions CAPS did not induce Ca2+
responses, but some spontaneous Ca2+ oscillations were still observable K) Suramin, a blocker of purinergic receptors, decreased the frequency of Ca2+ oscillations. L) Serum re-
administration to Du 145 cells evoked Ca2+ oscillations similar to responses to CAPS administration.M) Time-lapse recording of Du 145 cells transfected with GFP-labeled InsP3–5-
phosphatase. Most of transfected cells show the morphological appearance of apoptosis: cell shrinkage, nuclear condensation, blebs and detachment from surface. Bar represents 20 μm.
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inositol phospholipid pathway [27,32]. This procedure applied to
Du 145 cells resulted in the generation of similar oscillations in ccyt
(80–95% responding cells), as was observed after CAPS treatment
(Fig. 3L). Cells transfected with a plasmid encoding both GFP and
InsP3–5 phosphatase were monitored. After 72 h, approximately 30–
40% of transfected cells showed the morphological signs of apoptosis:
cell shrinkage, nuclear condensation, membrane blebs, cell detachment
from the culture plate and appearance of apoptotic bodies (Fig. 3M).
These cells were also positive to Annexin V-Cy3 red staining (apoptosis
indicator) (Supplementary Fig. S5, upper row). In a control experiment
cells were transfected with the plasmid pEGFP-C1 encoding only GFP
protein. Clearly less cells, approximately 5% of transfected cells were
positive for Annexin V-Cy3 staining (Supplementary Fig. S5, lower
row). Our ﬁnding that blocking of the Ca2+ oscillations by InsP3–5
phosphatase overexpression reduced cell viability indicates that the
inositol phospholipid pathwayplays an important role in the physiology
of Du 145 cells.
3.4. Increase in cmito leads to ATP production in CAPS-treated Du 145 cells
In hepatocytes and primary mesothelial cells oscillations in ccyt acti-
vate mitochondrial enzymes and also augment mitochondrial function
[32,33]. Although ATP production in cancer cells is mainly based on aer-
obic glycolysis, mitochondria are implicated in ATP production also in
tumor cells [34]. The oscillations in ccyt evoked by CAPS resulted in con-
comitant changes in the free mitochondrial matrix Ca2+ concentration
(cmito) (Fig. 4A). As observed before inmesothelial cells [32], the chang-
es in cmito occurred with a small time delay compared to the ccyt signals
(Fig. 4A). The addition of CAPS also slightly increased themitochondrial
membrane potential (ΔΨ), however the increase was not signiﬁcant
(Fig. 4B). In comparison to untreated cells, CAPS treatment resulted in
a small, yet signiﬁcant increase in ATP production in Du 145 cells, evi-
denced by a side-by-side comparison of untreated vs. CAPS-treated Du
145 cells measured 2 and 5min after CAPS addition (Fig. 4C). Collapsing
of the mitochondrial membrane potential by the uncoupler carbonyl
cyanide m-chlorophenyl hydrazone (CCCP; Fig. 4B)) diminished ATP
production despite the concomitant presence of the TRPV1 agonist
CAPS (Fig. 4C).
3.5. CAPS treatment of DRG neurons but not of NIH-3 T3 cells ectopically
expressing TRPV1 results in Ca2+ oscillations
Recently, we have demonstrated that DRG neurons express higher
levels of TRPV1 channels than cancer cells. Moreover, activation of
sensory neurons with 20 μMCAPS leads to overstimulation-based cyto-
toxicity in sensory neurons with signal plateau-type responses in ccyt
[22,35]. Yet at lower CAPS concentrations in the range of 1 μM approx-
imately 30–40% of DRG neurons showed Ca2+ oscillations (Fig. 5A).
Similar experiments were carried out in NIH-3T3 cells characterized
by very low to none endogenous TRPV1 expression [25] and treatment
with 50 μMCAPS had no effect on ccyt (0% of responding cells) (Fig. 5B).
When these cells were transfected with plasmids coding for either
human or rat TRPV1 channels, addition of CAPS (50 μM) resulted in
rapid signal-plateau Ca2+ responses in 15–28% of cells, thus allowing
to quickly identifying the transfected (TRPV1+) subpopulation of
end of the experiment. Cells were ﬁrst treated with a low CAPS concen-
tration (50 nM), followed by 50 μM CAPS several minutes later. In all
responding cells one of the four following patterns were observed:
Type I) In 2–3% of cells, strong signal-plateau Ca2+ responses were ob-
served already after administration of 50 nM CAPS (e.g. green trace in
Fig. 5C), most probably indicative of high levels of ectopic TRPV1 ex-
pression. Type II) In 9–15% of cells, after a weak and prolonged Ca2+ in-
crease evoked by 50 nM CAPS, ccyt slowly recovered to baseline levels,
usually within 5–7 min after treatment. This was followed by strong
signal-plateau responses evoked by 50 μM CAPS (e.g. red trace in
Fig. 5C). Type III) Cells (6–11%) didn't respond to low CAPS exposure,
but displayed strong responses to high CAPS concentration (e.g. blue
trace in Fig. 5C). Type IV) Cells (72–85%) that didn't respond to 50 μM
CAPSwere assumed to comprise the TRPV1- subpopulation (e.g. orange
trace in Fig. 5C). Of note in all conditions, no Ca2+ oscillations were ob-
servable. Essentially identical results were obtained, when cells stably
overexpressed rat TRPV1. The same four behaviors towards low and
high CAPS exposure were observed (Type I, Type II, Type III and Type
IV responses in 24–30%, 43–52%, 17–26% and 1–5%of cells, respectively)
and these cells showed neither spontaneous nor CAPS-evoked Ca2+
oscillations. (Fig. 5D). Thus, these results indicated that overexpression
of TRPV1 alone is not sufﬁcient to produce Ca2+ oscillations.
Circumventing the need for TRPV1 signaling by transient serum
withdrawal followed by serum re-administration resulted in clear
Ca2+ oscillations in NIH-3T3 cells (80–90% of responding cells;
Fig. 5E), which was strongly blocked by U-73122 pre-treatment
(Fig. 5F). This indicated that the inositol phospholipid pathway is indeed
intact inNIH-3T3 cells, but that stimulation of ectopic TRPV1was unable
to induce this activation. The reason for this may be manifold; one pos-
sibility is that TRPV1 is associated with a linker protein required to indi-
rectly activate the inositol phospholipid pathway. Of note, ectopic
human TRPV1-expressing NIH-3 T3 cells stimulated with 50 μM CAPS
showed a long-lasting Ca2+ signal resembling the one evoked by
the Ca2+ ionophore ionomycin (Fig. 5G). The ionomycin treatment
(100% responding cells) rendered both plasma and ERmembranes per-
meable for Ca2+ ions but also did not link the ccyt increase to the activa-
Fig. 4. CAPS-mediated cytoplasmic Ca2+ oscillations in Du 145 cells lead to increases
in cmito and ATP synthesis A) Simultaneous measurement of ccyt and cmito revealed
that oscillations in ccyt led to oscillations in cmito with a slight time delay. A
representative recording of ccyt (green) and cmito (red) in a Du 145 cell is shown. B)
Oscillations in cmito slightly increased the mitochondrial potential (ΔΨ), which collapsed
after administration of 100 μM CCCP. Figure represents the results of one representative
experiment out of three with similar results. C) Upon CAPS stimulation ATP production
was signiﬁcantly increased 2 and 5 min after stimulation compared to vehicle-treated
cells. CAPS (50 μM) administration in the presence of the uncoupler CCCP (500 μM)
resulted in decreased ATP production compared to the vehicle-treated cells. Each
column represents the result of N10 independent samples (mean ± s.d.). Signiﬁcant
differences between samples are marked with * (p b 0.05).
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TRPV1-mediated and ionomycin-induced elevations in ccyt was their
dependence on extracellular Ca2+. The ionomycin-evoked increase in
ccyt didn't differ much, whether extracellular Ca2+ was high or low
(Fig. 5G) indicating that the majority of Ca2+ ions leading to the tran-
sient increase in ccyt was derived from internal stores. The TRPV1-
mediated CAPS-induced Ca2+ signal was signiﬁcantly smaller in low ex-
tracellular Ca2+ conditions indicative of an essential contribution of
plasmamembrane-located TRPV1 in the increase of ccyt (Fig. 5H). How-
ever, irrespective of the Ca2+ source (internal store, extracellular) the
robust increase in ccyt was not leading to oscillations. HEK 293 cells, sim-
ilarly to NIH-3T3 cells, are characterized by very low to none endoge-
nous TRPV1 expression [36]. These cells didn't respond to CAPS
treatment (Fig. 5I). Overexpression of TRPV1 channels resulted in the
same four behaviors towards low and high CAPS exposure observed
before in NIH-3T3 (Type I, Type II, Type III and Type IV responses in
15–38%, 15–27%, 13–21% and 18–32% of cells, respectively (Fig. 5J).
However approximately 5–13% of cells showed Ca2+ oscillations or sin-
gle Ca2+ spikes after 50 nM CAPS stimulation. Since these oscillating
cells didn't respond to high CAPS (50 μM) with constant elevated ccyt,
we presume that these cells consisted of non-transfected cells. Of
note, those cells were always next neighbors of a highly sensitive
TRPV1-expressing cells (Fig. 5K). Currently we can't provide a clear ex-
planation for this ﬁnding. We hypothesize that TRPV1-expressing
highly-sensitive cellsmight release some agonistmolecule(s) that affect
the oscillatory behavior of a neighboring TRPV1-negative cell.
4. Discussion
Activation of TRPV1 channels by endogenous compounds or phar-
macological substances such as CAPS may lead to various biological
responses in different cell types.Mild TRPV1 activation leads to prolifer-
ation of airway smoothmuscle cells [37] and is involved in the induction
of skeletal muscle hypertrophy [38]. TRPV1 expression in sensory neu-
rons is associated with pain and heat sensation [39]. Strong and persis-
tent activation of TRPV1 on sensory neurons leads to the elimination of
TRPV1-expressing neurons due to overstimulation-based cytotoxicity
Fig. 5. CAPS-mediated Ca2+ signals in DRG sensory neurons and in NIH-3 T3 cells ectopically expressing TRPV1 A)-E) Single-cell (colored traces) and average ﬂuorescence (grey
traces) recordings from time-lapse videos show changes in ccyt. Bars represent standard deviations (s.d.). Each ﬁgure represents the results of one representative experiment out of
three with similar results. A) A subset of cultured rat DRG neurons showed Ca2+ oscillations after CAPS (1 μM) treatment. B) Non-transfected NIH-3T3 cells do not respond to 50 μM
CAPS. C) Ectopic expression of human TRPV1 rendered NIH-3T3 cells extremely sensitive to CAPS resulting in signals already at 50 nM CAPS and even higher ones with 50 μM CAPS.
No oscillations were observed. D) Similar low magnitude, long-lasting elevations of ccyt, instead of Ca2+ oscillations, were observed when rat TRPV1 was ectopically overexpressed.
E) Ca2+ oscillations appeared when serum was re-administered to NIH-3 T3 cells. F) U-73,122 pre-treatment signiﬁcantly reduced the serum evoked response G) Ionomycin
treatment didn't result in Ca2+ oscillations and showed similar Ca2+ signals in the presence (black) or absence (red) of extracellular Ca2+. H) In the presence of extracellular Ca2+ ions
(black trace) the Ca2+ response after CAPS treatment was more pronounced in TRPV1-expressing NIH-3T3 cells in comparison to control cells maintained in the absence of
extracellular Ca2+ (red trace). I) Non-transfected HEK 293 cells didn't respond to 50 μM CAPS. J) Low or high magnitude, long-lasting elevations of ccyt, but not Ca2+ oscillations were
usually observed when human TRPV1 was ectopically overexpressed in HEK 293 cells. K) Few likely non-transfected HEK 293 cells (green traces), mainly in the neighborhood of a
highly sensitive transfected HEK 293 cell (blue curve) showed Ca2+ oscillations.
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found that production of InsP3 and continuous Ca2+ inﬂux across the
plasmamembrane are two essential and frequency-determining factors
for Ca2+ oscillations.
Prostate and breast cancer cells, previously shown to express TRPV1
transcripts and TRPV1 protein [22], produced CAPS-induced Ca2+
waves and Ca2+ oscillations. CAPS is a selective TRPV1 receptor agonist
with a half-maximal effective concentration for CAPS in sensory
neurons in the range of 200–700 nM [42,43]; CAPS evokes Ca2+ signals
at low nanomolar concentrations in heterologous expression systems.
In line, NIH-3 T3 cells overexpressing TRPV1 responded to 50 nM
CAPS with increases in ccyt (Figs. 5C, D). However, a concentration of
at least 5–50 μM CAPS was required to elicit Ca2+ responses in the
untransfected prostate and breast cancer cells. The lower CAPS sensitiv-
ity of cancer cells is likely linked to the lower TRPV1 expression levels in
these cells in comparison to TRPV1-expressing sensory neurons, esti-
mated to be at least 20-fold lower in the investigated cancer cell lines
[22]. Of relevance, the concentrations (5 μM and 50 μM) used in this
study were still below the concentration, where an unspeciﬁc effect of
CAPS was reported before. CAPS (250 μM and higher) blocks the respi-
ratory chain acting as a quinone analog [44]. CAPS-evoked responses
were inhibited by administration of CapZ, a genuine and competitive
TRPV1 agonist. Moreover, the ultrapotent and highly speciﬁc TRPV1 ag-
onist RTX and one of the endogenous TRPV1 agonists, 13-HODE, also
generated Ca2+ signals indicating the involvement of TRPV1 channels
in the process. In sensory neurons, exposure to 1 μMCAPSwas sufﬁcient
nel activation leads to InsP3 production is currently unknown; however
some hypotheses can be put forward. I) Activation of phospholipase C
by TRP channels is induced by Ca2+ ions transported by the TRP chan-
nels, as the activity of phospholipase C depends on increases in ccyt as re-
ported before [45]. Since merely an increase in ccyt did not lead to Ca2+
oscillations (Fig. 5B, C, E and F), we can conclude that this process does
not play a critical role in phospholipase C activation.However, the trans-
port of Ca2+ ions across the plasma membrane is important for the
maintenance of Ca2+ oscillations and also affecting the oscillation fre-
quency [27,32]. Thus, the amount of Ca2+ ions passing through TRPV1
channels sustains Ca2+ oscillations and inﬂuences the oscillation fre-
quency (Fig. 3C, D). II) TRPV1 channels are associated with G proteins
and upon stimulation, G proteins activate phospholipase C; an associa-
tion between TRPM8, another TRP family member, and Gαq proteins
has been described before [46]. The direct connection between TRPV1
andG proteins has to be elucidated in a future study. III) Previous exper-
iments in astrocytes and hepatocytes [30,31] indicate that ATP is the
molecule released by the wave-initiator cells. ATP binding to purinergic
receptors on neighboring cells then results in InsP3 production required
for the generation of Ca2+ oscillations and intercellular Ca2+ waves. In
analogy, we hypothesize that TRP channel stimulationmight induce ex-
tracellular ATP release, followed by InsP3 production in neighboring
cells resulting in Ca2+ signals in those cells. In support, the purinergic
receptor blocker suramin, effective in blocking of ATP-evoked Ca2+ os-
cillations, was not effective in blocking of the CAPS-induced oscillations,
Fig. 6. Proposed model for the role of TRPV1 channels in signal transmission. The observed CAPS-evoked Ca2+ signal is mainly the result of the activated phospholipid pathway
( i i l f 2+ f d l i i l ) d l ﬂ i h 2+ i i h h h h l h l l d 2+
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but reduced the Ca2+ oscillation frequency andmore importantly, Ca2+
wave formation.
Although in this study we focused on the effect of TRPV1 activation
on the phospholipid pathway, it is known that phospholipids them-
selves alsomodify the sensitivity and function of TRPV1 channels. Phos-
phatidylinositol 4,5-bisphosphate (PIP2), a precursor molecule for the
InsP3 production was found to sensitize TRPV1 channels to CAPS. Be-
sides of that, also phosphatidylinositol 4-phosphate PI(4)P was found
to sensitize the receptor [47]. Moreover, the depletion of PIP2 from
the plasma membrane, either alone or together with PI(4)P inhibits
TRPV1 channel function [47,48]. This process was shown to be involved
in the mechanism of TRPV1 desensitization [47]. Thus, we propose the
following negative feedback loop for TRPV1 regulation: TRPV1 channel
activity leads to phospholipase C activation, which, in turn, slowly de-
pletes PIP2 and PI(4)P from the membrane. This depletion then leads
to the inhibition of TRPV1 receptor resulting in a halt of the Ca2+
oscillations.
To getmoremechanistic insight in TRPV1-mediated Ca2+ responses,
we chose Du 145 prostate cancer cells. TRPV1 was involved both in the
induction and the maintenance of Ca2+ oscillations, i.e. by generating
InsP3 and mediating Ca2+ inﬂux via the plasma membrane. The
frequency of Ca2+ oscillations is implicated in regulating genes
driven by pro-inﬂammatory transcription factors such as NF-κB, NF-
AT and Oct./OAP [49]. Ca2+ oscillations were shown to activate Ras
and ERK/MAPK cascades controlling cell growth and differentiation
[50]. Moreover, Ca2+ oscillations induce ATP production energizing
many cellular processes [51]. In this study we also found that Ca2+
oscillations energized the mitochondria in Du 145 cells. Although the
abovementioned physiological processes are associated with increased
cell viability and mitogenic processes, there are only few studies
reporting that CAPS increase cell proliferation of cancer cells. While
CAPS (50 μM) increases the proportion of cells present in the G2
phase, the proportion of G0/G1 cells is decreased compared to control
(untreated) LNCaP cells [52]. Similarly Malagarie-Cazenave et al.
found that CAPS induced cell proliferation in LNCaP prostate cancer
cells in the same concentration range [53]. We also reported that 5–
50 μMCAPS treatment slightly, but inmany cases signiﬁcantly increases
the cell proliferation of breast and prostate cancer cells in vitro [22]. Be-
sides of that, we also reported CAPS-induced invadopodium formation
in MCF7 breast cancer cells [22]. Invadopodium is an amoeboid-like
structure involved in tumor cell motility [54].
Endogenous agonists of TRPV1 channels such as arachidonyl acid
derivatives and oxidized linoleic acid metabolites are present in the
tumor milieu [55]. It has been known for a long time - even before
TRP channels were discovered - that endogenous agonists of TRP
channels (lipoxygenase products) promote tumor growth [56]. Howev-
er, the experimental evidence that the mitogenic, growth-promoting
effects of lipoxygenase products are mediated by TRPV1 has never
been described before. The oxidized linoleic acid metabolite 13-S-
hydroxyoctadecadienoic acid (13-HODE)was observed in human pros-
tate adenocarcinoma specimens, whereas adjacent normal tissue
showed no immunoreactivity for 13-HODE [57]. Similarly, a low pH in
the extracellular milieu, another activator of TRPV1 [58], is also associ-
ated with inﬂammation and the cancer microenvironment [59,60].
LNCaP cells produce high amounts of 20-hydroxyeicosatetraeonic acid
(20-HETE) [61], another endogenous activator of TRPV1 channels [62].
Expression of 12-lipoxygenase, the enzyme involved in generation
of 12(S)-hydroxyeicosatetraeonic acid (12-HETE), was found to
correlate with more malignant stages of prostate cancer [63,64].
12-HETE is an endogenous TRPV1 ligand known to increase the ﬁring
rate of sensory neurons via TRPV1 activation [65]. Most probably, the
TRPV1 channel is the “putative G protein linked receptor [55]”
involved in the proliferative effect of the lipoxygenase pathway
product.
In summary, endogenous TRPV1 channels are connected with the
inositol phospholipid pathway. The observed CAPS-evoked Ca2+ signals
are the result of the activated phospholipid pathways and not only
the Ca2+ ions passing through the TRPV1 channels. Since TRPV1 chan-
nels alone cannot produce Ca2+ oscillations, the analog amplitude-
modulated (AM) increase in ccyt is processed by inositol phospholipid
pathway. The inositol phospholipid pathway acts as an ampliﬁer and
“analog to digital converter” to generate the frequency-modulated
(FM) output (Ca2+ oscillations) for a given Ca2+ signal produced by
TRPV1 activation (for details, see model in Fig. 6). In cancer cells, one
might envisage the following pathophysiological processes: increased
levels of endogenous agonists present in the cancer microenvironment
activate TRPV1 channels; the resulting Ca2+ inﬂux via TRP channels to-
gether with increased InsP3 production induces Ca2+ oscillations and
these Ca2+ oscillations (FM mode) activate Ca2+ signaling-dependent
transcription factors involved in cell proliferation. I.e. auto- or paracrine
TRPV1 channel activation in cancer cells might promote their survival
and possibly increase their proliferation rate in vivo.
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